Intended for healthcare professionals

  1. Research
  2. Doctors and patients...
  3. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis
Papers

Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis

BMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7094.1580 (Published 31 May 1997) Cite this as: BMJ 1997;314:1580

Related articles

See more

Cited by...

  • Physical activity assessment among patients with multiple sclerosis in Saudi Arabia
  • Priorities of patients with multimorbidity and of clinicians regarding treatment and health outcomes: a systematic mixed studies review
  • Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves' hyperthyroidism undergoing radioiodine therapy: a randomized controlled study
  • Stakeholder Engagement in a Patient-Reported Outcomes (PRO) Measure Implementation: A Report from the SAFTINet Practice-based Research Network (PBRN)
  • Health outcomes for children with neurodisability: what do professionals regard as primary targets?
  • Determinants of Patient Satisfaction After Severe Lower-Extremity Injuries
  • Different priorities: a comparison of parents' and health professionals' perceptions of quality of life in quadriplegic cerebral palsy
  • Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment
  • The role of pain and function in determining patient satisfaction after total knee replacement: DATA FROM THE NATIONAL JOINT REGISTRY FOR ENGLAND AND WALES
  • Quality of life: Listen to, change, or shoot the messenger?
  • Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL)
  • The effect of deep brain stimulation on quality of life in movement disorders
  • Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis
  • A comparison of health utility measures for the evaluation of multiple sclerosis treatments
  • The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis
  • Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002
  • Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles
  • The 12 year prognosis of unilateral functional weakness and sensory disturbance
  • Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12)
  • Quality of life with macular degeneration: perceptions of patients, clinicians, and community members
  • Measuring the meaning of disability in rheumatoid arthritis: the Personal Impact Health Assessment Questionnaire (PI HAQ)
  • Benefit of interferon {beta}-1a on MSFC progression in secondary progressive MS
  • Home based management in multiple sclerosis: results of a randomised controlled trial
  • Quality of Life Measurement After Stroke: Uses and Abuses of the SF-36
  • Interferon-{beta}1b in the treatment of secondary progressive MS: Impact on quality of life
  • Values for function in rheumatoid arthritis: patients, professionals, and public
  • Determinants of overall quality of life in secondary progressive MS: A longitudinal study
  • The SF-36 in multiple sclerosis: why basic assumptions must be tested
  • Measuring quality of life: Who should measure quality of life?
  • Unmet needs in multiple sclerosis: the role of community services
  • Neurological rehabilitation: from mechanisms to management
  • Memory Dysfunction in Multiple Sclerosis Corresponds to Juxtacortical Lesion Load on Fast Fluid-Attenuated Inversion-Recovery MR Images
  • Quality of life in multiple sclerosis: Measuring the disease effects more broadly
  • Validation of Italian multiple sclerosis quality of life 54 questionnaire
  • Health outcome measures
  • Sex and relationship dysfunction in neurological disability
  • Quality of life in multiple sclerosis in France, Germany, and the United Kingdom
  • Quality of life in multiple sclerosis
  • Assessment of Clinical Outcomes in Acute Stroke Trials
  • Patients' assessments of disability in multiple sclerosis
  • DOCTORS AND PATIENTS DISAGREE ON OUTCOME ASSESSMENTS IN MS
Back to top